Detection of ATTR Aggregates in the Plasma of Polyneuropathic Patients with ATTR-V30M Amyloidosis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis.
Gulati J, Pedretti R, Hendren N, Kozlitina J, Saelices L, Roth L Curr Heart Fail Rep. 2025; 22(1):8.
PMID: 39945945 DOI: 10.1007/s11897-025-00696-y.
References
1.
Ruberg F, Maurer M
. Cardiac Amyloidosis Due to Transthyretin Protein: A Review. JAMA. 2024; 331(9):778-791.
PMC: 11167454.
DOI: 10.1001/jama.2024.0442.
View
2.
Jiang X, Labaudiniere R, Buxbaum J, Monteiro C, Novais M, Coelho T
. A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction. Proc Natl Acad Sci U S A. 2021; 118(9).
PMC: 7936353.
DOI: 10.1073/pnas.2016072118.
View
3.
Pedretti R, Wang L, Hanna M, Benson M, Grodin J, Tang W
. Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis. Circulation. 2024; 149(21):1696-1699.
PMC: 11107565.
DOI: 10.1161/CIRCULATIONAHA.123.067225.
View
4.
Pedretti R, Wang L, Yakubovska A, Zhang Q, Nguyen B, Grodin J
. Structure-Based Probe Reveals the Presence of Large Transthyretin Aggregates in Plasma of ATTR Amyloidosis Patients. JACC Basic Transl Sci. 2024; 9(9):1088-1100.
PMC: 11494390.
DOI: 10.1016/j.jacbts.2024.05.013.
View
5.
Tozza S, Severi D, Spina E, Iovino A, Aruta F, Ruggiero L
. The neuropathy in hereditary transthyretin amyloidosis: A narrative review. J Peripher Nerv Syst. 2021; 26(2):155-159.
PMC: 8360044.
DOI: 10.1111/jns.12451.
View